André Goerke

André Goerke assumed the role of Chief Executive Officer at LenioBio in June 2023. 

Prior to joining LenioBio, André held the position of Head of Business Unit mRNA at Lonza, where he established and managed their inaugural mRNA manufacturing program. 

With a career spanning over 20 years, André has extensive experience from senior roles at Lonza and Novartis in strategic planning and operational leadership, successfully guiding global and local teams while implementing innovative operating models.